Whitepaper

Article | CMC Considerations for mRNA Based Therapeutics

Download

PDF 146 kB

Article | CMC Considerations for mRNA Based Therapeutics

This article discusses analytical approaches to characterise mRNA in early-stage development to support effective therapeutic programs.

Other Content from Intertek Pharmaceutical Services